Diagnostics & Research
The Diagnostics & Research industry has a total of 58 stocks, with a combined market cap of $662.5 billion, total revenue of $161.46 billion and a weighted average PE ratio of 58.57.
Market Cap
662.5B
Revenue
161.46B
Profits
11.31B
PE Ratio
58.57
Profit Margin
7.01%
Dividend Yield
0.24%
57 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 193.97B | -1.10% | 870,322 | 42.88B |
| 2 | DHR | Danaher Corporation | 151.86B | -0.15% | 2,022,653 | 23.88B |
| 3 | A | Agilent Technologies, Inc. | 34.35B | -1.21% | 991,068 | 6.53B |
| 4 | IDXX | IDEXX Laboratories, Inc. | 34.00B | -1.30% | 877,696 | 3.90B |
| 5 | IQV | IQVIA Holdings Inc. | 31.98B | -2.55% | 1,290,577 | 15.41B |
| 6 | MTD | Mettler-Toledo International Inc. | 25.01B | -1.35% | 92,646 | 3.87B |
| 7 | WAT | Waters Corporation | 21.89B | -1.25% | 453,878 | 2.96B |
| 8 | NTRA | Natera, Inc. | 20.91B | 0.56% | 1,044,330 | 1.70B |
| 9 | LH | Labcorp Holdings Inc. | 19.62B | -0.84% | 637,701 | 13.01B |
| 10 | DGX | Quest Diagnostics Incorporated | 18.39B | -0.96% | 769,212 | 9.87B |
| 11 | ICLR | ICON Public Limited Company | 14.46B | -2.94% | 945,649 | 8.28B |
| 12 | ILMN | Illumina, Inc. | 13.86B | -0.59% | 2,804,264 | 4.37B |
| 13 | RVTY | Revvity, Inc. | 12.91B | -1.09% | 1,290,812 | 2.76B |
| 14 | MEDP | Medpace Holdings, Inc. | 9.87B | -1.96% | 266,099 | 2.11B |
| 15 | QGEN | Qiagen N.V. | 8.57B | -0.33% | 779,823 | 1.98B |
| 16 | EXAS | Exact Sciences Corporation | 8.48B | -3.02% | 1,461,999 | 2.76B |
| 17 | CRL | Charles River Laboratories International, Inc. | 8.25B | -3.35% | 516,260 | 4.05B |
| 18 | GH | Guardant Health, Inc. | 5.74B | -0.53% | 1,304,364 | 739.02M |
| 19 | RDNT | RadNet, Inc. | 3.75B | -2.16% | 503,599 | 1.83B |
| 20 | SHC | Sotera Health Company | 3.38B | -2.38% | 1,022,126 | 1.10B |
| 21 | WGSWW | GeneDx Holdings Corp. | 2.90B | 5.65% | 50,238 | 305.45M |
| 22 | WGS | GeneDx Holdings Corp. | 2.83B | -2.38% | 498,203 | 305.45M |
| 23 | TWST | Twist Bioscience Corporation | 2.64B | -1.49% | 664,607 | 330.19M |
| 24 | VCYT | Veracyte, Inc. | 2.63B | 1.60% | 890,150 | 445.76M |
| 25 | NEOG | Neogen Corporation | 1.83B | -4.63% | 3,269,091 | 913.83M |
| 26 | NEO | NeoGenomics, Inc. | 1.28B | -1.97% | 1,179,031 | 660.57M |
| 27 | OPK | OPKO Health, Inc. | 1.21B | -0.28% | 1,721,402 | 713.14M |
| 28 | GRAL | GRAIL, Inc. | 1.06B | -2.83% | 662,358 | 125.60M |
| 29 | CDNA | CareDx, Inc | 1.06B | -2.80% | 519,591 | 333.79M |
| 30 | MYGN | Myriad Genetics, Inc. | 888.44M | -2.51% | 559,206 | 837.60M |
| 31 | CSTL | Castle Biosciences, Inc. | 594.23M | -0.67% | 167,055 | 332.07M |
| 32 | FLGT | Fulgent Genetics, Inc. | 525.64M | 0.59% | 528,637 | 283.47M |
| 33 | PSNL | Personalis, Inc. | 318.63M | -5.99% | 1,256,982 | 84.61M |
| 34 | STIM | Neuronetics, Inc. | 277.96M | -6.53% | 1,109,707 | 74.89M |
| 35 | ATLN | Atlantic International Corp. | 272.93M | -8.87% | 49,300 | 429.26M |
| 36 | ACRS | Aclaris Therapeutics, Inc. | 180.22M | -1.76% | 1,104,713 | 18.72M |
| 37 | BDSX | Biodesix, Inc. | 117.50M | -3.08% | 196,439 | 71.32M |
| 38 | OCX | OncoCyte Corporation | 88.09M | -7.51% | 93,133 | 1.88M |
| 39 | NOTV | Inotiv, Inc. | 87.38M | -11.03% | 485,599 | 475.11M |
| 40 | FONR | FONAR Corporation | 86.48M | -0.44% | 4,966 | 101.57M |
| 41 | MDXH | MDxHealth SA | 75.19M | 0.63% | 39,445 | 90.05M |
| 42 | XGN | Exagen Inc. | 68.91M | -4.94% | 138,901 | 55.64M |
| 43 | BNR | Burning Rock Biotech Limited | 49.45M | -15.14% | 89,428 | 70.67M |
| 44 | PRE | Prenetics Global Limited | 49.36M | -4.72% | 48,950 | 25.56M |
| 45 | ENZ | Enzo Biochem, Inc. | 23.74M | -7.53% | 60,855 | 29.09M |
| 46 | ME | 23andMe Holding Co. | 17.44M | -10.95% | 3,051,788 | 208.78M |
| 47 | PRPH | ProPhase Labs, Inc. | 14.36M | 10.67% | 9,676,287 | 12.75M |
| 48 | MYNZ | Mainz Biomed N.V. | 14.25M | -8.44% | 145,526 | 917.20K |
| 49 | PRPO | Precipio, Inc. | 10.04M | 1.50% | 1,231 | 17.41M |
| 50 | STRR | Star Equity Holdings, Inc. | 7.88M | -7.87% | 17,993 | 53.36M |
| 51 | XWEL | XWELL, Inc. | 5.38M | -1.54% | 248,371 | 33.83M |
| 52 | CHEK | Check-Cap Ltd. | 5.21M | -2.20% | 16,315 | - |
| 53 | BIAF | bioAffinity Technologies, Inc. | 4.40M | -2.01% | 146,850 | 9.37M |
| 54 | APDN | Applied DNA Sciences, Inc. | 2.31M | -1.42% | 3,227,152 | 3.74M |
| 55 | NDRA | ENDRA Life Sciences Inc. | 2.30M | -4.68% | 4,031 | - |
| 56 | AWH | Aspira Women's Health Inc. | 1.42M | -9.95% | 1,885,424 | 8.96M |
| 57 | ISPC | iSpecimen Inc. | 1.31M | 0.74% | 30,591 | 10.39M |